Efficacy and safety of semaglutide versus canagliflozin as add-on to metformin in subjects with type 2 diabetes
Phase of Trial: Phase III
Latest Information Update: 25 Jan 2019
At a glance
- Drugs Semaglutide (Primary) ; Canagliflozin
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms SUSTAIN 8
- Sponsors Novo Nordisk
- 05 Dec 2018 Status changed from active, no longer recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 25 Oct 2017 Status changed from recruiting to active, no longer recruiting.